Dosage-Dependent Antifungal Efficacy of V-Echinocandin (LY303366) against Experimental Fluconazole-Resistant Oropharyngeal and Esophageal Candidiasis

V-echinocandin (VER-002; LY303366) is a semisynthetic derivative of echinocandin B and a potent inhibitor of fungal (1, 3)-β-d-glucan synthase. We studied the antifungal efficacy, the concentrations in saliva and tissue, and the safety of VER-002 at escalating dosages against experimental oropharyng...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Petraitis, Vidmantas, Petraitiene, Ruta, Groll, Andreas H., Sein, Tin, Schaufele, Robert L., Lyman, Caron A., Francesconi, Andrea, Bacher, John, Piscitelli, Stephen C., Walsh, Thomas J.
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2001
主題:	Experimental Therapeutics
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90315/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11158743/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.2.471-479.2001
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!